Photophobia News and Research

RSS
CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

New study holds promise for patients with LCA

New study holds promise for patients with LCA

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Aspirin can reduce acute migraine attacks

Aspirin can reduce acute migraine attacks

Persisting red, itchy, watery eyes in children may be signs of serious conditions

Persisting red, itchy, watery eyes in children may be signs of serious conditions

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Phase 3 trial results of LEVADEX orally inhaled migraine therapy to be presented

Phase 3 trial results of LEVADEX orally inhaled migraine therapy to be presented

Phase III trial demonstrates rapid efficacy of Zelrix in treating acute migraine

Phase III trial demonstrates rapid efficacy of Zelrix in treating acute migraine

Aton Pharma markets preservative-free drugs for glaucoma

Aton Pharma markets preservative-free drugs for glaucoma

Investigational, orally-inhaled therapy effective in treating migraines

Investigational, orally-inhaled therapy effective in treating migraines

Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review

Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review

Aton Pharma acquires Timoptic product line from Merck & Co

Aton Pharma acquires Timoptic product line from Merck & Co

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

ISTA Pharmaceuticals announces trial results for topical Xibrom 0.09%

Combination of sumatriptan and naproxen sodium for migraine more effective than single medications

Combination of sumatriptan and naproxen sodium for migraine more effective than single medications

Multimechanism-targeted therapy for migraine more effective than single medications

Multimechanism-targeted therapy for migraine more effective than single medications

College freshmen, beware of dorm diseases

College freshmen, beware of dorm diseases

Study shows frovatriptan effective in preventing menstrual associated migraine

Study shows frovatriptan effective in preventing menstrual associated migraine